Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Pregnancy
Interventions: Brick device; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cystic Fibrosis (CF)
Interventions: As-needed hypertonic saline (HS), Twice daily hypertonic saline (HS), As-needed dornase alfa (DA), Daily dornase alfa (DA); Other
Lead sponsor: Nicole Hamblett; Other
Eligibility: 3 Years to 16 Years
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 36
States / cities: Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 32 more

Conditions: Tobacco Dependence Treatment, Lung Cancer Screening
Interventions: External Facilitation; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related Conditions, Vaginitis, Perimenopause
Interventions: Vaginal estradiol tablets, Vaginal moisturizer; Drug · Other
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Electronic Health Record Review, Spiritual Therapy, Survey Administration; Other · Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteoarthritis
Interventions: Mesenchymal Stem Cell Injection; Biological
Lead sponsor: TricelX Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Frisco, Texas

Conditions: Hydration, Dehydration (Physiology), Performance
Interventions: Water (Placebo), Carbohydrate Milk Permeate sports drink, 6% Sports drink, Low-Carbohydrate Milk Permeate sports drink; Dietary Supplement
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Idiopathic Scoliosis
Interventions: Scoliosis Correction System; Device
Lead sponsor: Globus Medical Inc; Industry
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Vaccine Confidence, Adolescent Vaccination, Vaccine Uptake
Interventions: Tailored Vaccine Messaging, Standard Vaccine Message; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Breast Cancer
Interventions: Sentinel node biopsy with blue dye and radioisotope; Diagnostic Test
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Soft Tissue Sarcoma
Interventions: Not listed
Lead sponsor: Power Life Sciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cancer-related Cognitive Impairment
Interventions: THOR LED Photobiomodulation Helmet - Therapeutic, THOR LED Photobiomodulation Helmet - Control; Device
Lead sponsor: Arash Asher, MD; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharynx Carcinoma, Nasopharynx Cancer
Interventions: Cemiplimab, Fianlimab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Neoplasm Cervix
Interventions: Curcumin C3 Complex, Placebo; Drug
Lead sponsor: Lisa Flowers; Other
Eligibility: 21 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Cystic Fibrosis
Interventions: micro Sweat Test Patch (mSTP), Sweat Testing using SOC; Device · Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 2 Weeks to 90 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Colorectal Cancer (Diagnosis), Adenoma
Interventions: S-Adenosylmethionine (SAMe); Drug
Lead sponsor: Jun Gong, MD; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression - Major Depressive Disorder, Irritability
Interventions: Kurvelo, Placebo COC; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 12 Years to 16 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Chapel Hill, North Carolina

Conditions: Postpartum Complication, Postpartum, PTSD, PTSD (Childbirth-Related), Infant Feeding Practices, Breastfeeding Education, Breastfeeding, Health Related Quality of Life, LACTATION IN MOTHERS WITH PREMATURE NEWBORNS
Interventions: NICU-informed postpartum doula support; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 11
States / cities: Bryn Mawr, Pennsylvania • King of Prussia, Pennsylvania • Lancaster, Pennsylvania + 6 more

Conditions: Overall Survival (All-cause Mortality)
Interventions: Control, Exercise; Behavioral
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 55 Years to 74 Years
Enrollment: 19,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: Chronic Pain
Interventions: Spinal Cord Stimulation (SCS) System; Device
Lead sponsor: Dustin Reynolds, MD; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pancreas Cancer, Metastatic, Pancreas Carcinoma
Interventions: STRONG intervention App, individualized remote dietitian; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: HIV Prevention
Interventions: Education and Mentoring for Prescribing Pharmacists; Other
Lead sponsor: Xavier University of Louisiana.; Other
Eligibility: 24 Years to 99 Years
Enrollment: 75 participants
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Head & Neck Cancer
Interventions: Impact Advanced Recovery (Impact AR), Boost® High Protein + Beneprotein®; Dietary Supplement
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Keratinized Tissue Augmentation Around Dental Implants
Interventions: Augmented Gingival Matrix graft, Free Gingival Graft; Device · Procedure
Lead sponsor: The Forsyth Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Somerville, Massachusetts

Search by objective public record fields.

Social Media Withdrawal in Pregnancy: Effects on Maternal Mental Health and Misinformation

Rethinking Early Airway Clearence Therapies

ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening

Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV

Blessing Stem Cells to Improve Spiritual Well Being and Quality of Life for Patients Undergoing Hematopoietic Stem Cell Transplantation

The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis

The Role of Carbohydrate Blends and Electrolytes on Physical and Mental Performance During Cycling in the Heat

A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis

Tailored Vaccine Messaging for Parents/Caregivers of Adolescents

Feasibility and Effectiveness of Sentinel Lymph Node Biopsy in Inflammatory Breast Cancer

Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study

Photobiomodulation for Cancer-Related Cognitive Impairment

A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma

Topical Curcumin for HPV Related Cervical Disease

Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function

S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas

Teen Vulnerability to Irritability: Brain and Estrogen Changes

Postpartum Care in the NICU Multi-Site Breastfeeding

Exercise and Mortality in Middle-Aged and Older Adults

EVA: Evaluation of EVOKE Therapy Metrics Generated Using the Evoke System With EVA

The STRONG Nutrition Support Study for People With Pancreatic Cancer

Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

Gut-Liver-Muscle Axis in Cancer Cachexia

Keratinized Tissue Augmentation Using Augmented Gingival Matrix Compared to Free Gingival Graft Around Implants